We are live on
!
Find out more
C
Consulta Portfolio holdings
AUM
$2.77B
1-Year Est. Return
3.62%
This Fund
S&P 500
This Quarter
Est. Return
-3.94%
1 Year Est. Return
+3.62%
3 Year Est. Return
+30.69%
5 Year Est. Return
+30.14%
10 Year Est. Return
+206.35%
AUM
$1.53B
AUM Growth
-$92.8M
(-5.7%)
Cap. Flow
-$30.6M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
90.51%
Holding
15
New
–
Increased
4
Reduced
5
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$96.1M |
| 2 |
Canadian Pacific Kansas City
CP
|
+$84.8M |
| 3 |
Microsoft
MSFT
|
+$31.9M |
| 4 |
Danaher
DHR
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$82M |
| 2 |
Walt Disney
DIS
|
+$48.1M |
| 3 |
JPMorgan Chase
JPM
|
+$46.6M |
| 4 |
QXO
QXO Inc
QXO
|
+$40.9M |
| 5 |
Visa
V
|
+$19.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.94% |
| 2 | Financials | 18.26% |
| 3 | Industrials | 16.01% |
| 4 | Consumer Discretionary | 14.05% |
| 5 | Communication Services | 12.4% |
Similar funds
HCM
BGM
SIM
JHP
DJSG
CAAS
CCM
FFA
Consulta's Q4 2024 Portfolio in Review
As of Q4 2024, Consulta held 15 positions worth $1.53B, down 5.7% from $1.62B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Consulta's Q4 2024 filing shows 4 increased, 5 reduced and 2 closed positions. The largest sale was Canadian National Railway, an estimated $82M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Consulta added most to HCA Healthcare in Q4 2024, an estimated $96.1M increase.
- Consulta's biggest Q4 2024 reduction was JPMorgan Chase, cutting an estimated $46.6M.
- Consulta fully exited Canadian National Railway in Q4 2024, selling an estimated $82M.
- Consulta's ten largest holdings make up 91% of its $1.53B portfolio in Q4 2024.
- Consulta opened 0 new positions and closed 2 in Q4 2024.
- Consulta's portfolio value fell 5.7% quarter-over-quarter to $1.53B.
Based on Consulta's 13F filing for Q4 2024, filed 14 Feb 2025.